Neurontin (gabapentin)
April 25, 2005
Audience: Neuropsychiatric healthcare professionals, pharmacists and consumers
Pfizer Inc. and FDA notified healthcare professionals of the voluntary recall of one lot (40,000 bottles) of 100 mg capsules of its epilepsy medication, Neurontin, after a manufacturing mechanical failure resulted in some bottles containing empty or partially filled capsules. Patients taking Neurontin to control epilepsy could experience seizures from a missed dose of the product. 100 mg strength capsules from lot #15224V -- distributed in October and November, 2004 -- are included in the recall. The production lot was distributed only in the United States. No other Neurontin lots were affected.[April 22, 2005 - Press Release - Pfizer]
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.